Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...
SESAUA 2024: Time Interval Between Radium-223 Therapy and 177Lu-PSMA Treatment for mCRPC and Outcomes in the RALU Study SESAUA 2024: State of the Art Lecture: Management of Complications Following ...
Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...
ESMO 2024: Identification of Bladder Cancer Patients That Could Benefit from Early Post-Cystectomy Immunotherapy Based on Serial Circulating Tumour DNA Testing: Preliminary Results from the TOMBOLA ...
SNMMI 2023: PSMA PET Prognostic Value for Outcome of Pre-Chemotherapy Post-ARSI CRPC Patients: A Single Center Retrospective Analysis SNMMI 2023: 68Ga-PSMA PET/CT-Based Multivariate Model for Highly ...
ESMO 2024: Clinical Prognostic Factors Within the High-Volume Subgroup of Metastatic Hormone Sensitive Prostate Cancer in ENZAMET (ANZUP 1304) ESMO 2024: HARMONY: A Phase II Study of ...
Robotic versus Open Cystectomy with Ileal Conduit for the Management of Neurogenic Bladder: A Comparative Study - Beyond the Abstract ...
Antioxidants for Male Infertility: Therapeutic Scheme and Indications. A Retrospective Single-Center Real-Life Study - Beyond the Abstract ...
Transperineal Laser Ablation in the Management of Benign Prostatic Hyperplasia: An Updated Systematic Review and Pooled Analysis - Beyond the Abstract ...
ESMO 2023: Usefulness and Limitations of PSMA Imaging/PET in High-Risk Localized Disease ESMO 2023: Patient-Reported Outcomes in Men with mCRPC and HRR Mutations Receiving Talazoparib + Enzalutamide ...
Relationship Between the Frequency of Electrocautery of Hunner Lesions and Changes in Bladder Capacity in Patients with Hunner Type Interstitial Cystitis - Beyond the Abstract ...
ASCO 2024: FGFR3 Alterations in Patients Who Develop Locally Advanced or Metastatic Urothelial Cancer, and Their Association with Tumor Subtype and Clinical Outcomes in Patients Treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results